Boyd Watterson Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45K | Hold |
435
| – | – | 0.01% | 194 |
|
|
2026
Q1 | $31.2K | Hold |
435
| – | – | 0.01% | 216 |
|
|
2025
Q4 | $34.5K | Hold |
435
| – | – | 0.01% | 210 |
|
|
2025
Q3 | $32.8K | Hold |
435
| – | – | 0.01% | 211 |
|
|
2025
Q2 | $30K | Hold |
435
| – | – | 0.01% | 220 |
|
|
2025
Q1 | $29.5K | Hold |
435
| – | – | 0.01% | 226 |
|
|
2024
Q4 | $19.5K | Hold |
435
| – | – | 0.01% | 263 |
|
|
2024
Q3 | $27.4K | Hold |
435
| – | – | 0.01% | 230 |
|
|
2024
Q2 | $25.7K | Hold |
435
| – | – | 0.01% | 234 |
|
|
2024
Q1 | $34.7K | Hold |
435
| – | – | 0.01% | 208 |
|
|
2023
Q4 | $34.3K | Hold |
435
| – | – | 0.01% | 209 |
|
|
2023
Q3 | $30.4K | Hold |
435
| – | – | 0.01% | 214 |
|
|
2023
Q2 | $30.1K | Sell |
435
-440
| -50% | -$31.3K | 0.01% | 220 |
|
|
2023
Q1 | $65K | Sell |
875
-540
| -38% | -$45.3K | 0.03% | 179 |
|
|
2022
Q4 | $132K | Buy |
+1,415
| New | +$137K | 0.05% | 145 |
|
|
2020
Q4 | – | Sell |
-3,427
| Closed | -$200K | – | 133 |
|
|
2020
Q3 | $200K | Sell |
3,427
-6
| -0.2% | -$373 | 0.11% | 120 |
|
|
2020
Q2 | $223K | Buy |
+3,433
| New | +$216K | 0.15% | 106 |
|
|
2020
Q1 | – | Sell |
-3,425
| Closed | -$254K | – | 108 |
|
|
2019
Q4 | $254K | Buy |
+3,425
| New | +$240K | 0.17% | 107 |
|
|
2019
Q1 | – | Sell |
-8,632
| Closed | -$566K | – | 119 |
|
|
2018
Q4 | $566K | Buy |
8,632
+3,767
| +77% | +$281K | 0.41% | 71 |
|
|
2018
Q3 | $383K | Buy |
4,865
+657
| +16% | +$47K | 0.22% | 101 |
|
|
2018
Q2 | $271K | Buy |
4,208
+250
| +6% | +$16.5K | 0.16% | 112 |
|
|
2018
Q1 | $246K | Buy |
3,958
+50
| +1% | +$3.59K | 0.12% | 129 |
|
|
2017
Q4 | $283K | Sell |
3,908
-3,570
| -48% | -$260K | 0.14% | 127 |
|
|
2017
Q3 | $608K | Sell |
7,478
-1,230
| -14% | -$97.3K | 0.3% | 94 |
|
|
2017
Q2 | $701K | Buy |
8,708
+1,029
| +13% | +$81.3K | 0.36% | 84 |
|
|
2017
Q1 | $603K | Buy |
7,679
+1,690
| +28% | +$135K | 0.3% | 91 |
|
|
2016
Q4 | $473K | Sell |
5,989
-6,375
| -52% | -$516K | 0.25% | 104 |
|
|
2016
Q3 | $1.1M | Buy |
12,364
+1,373
| +12% | +$130K | 0.54% | 56 |
|
|
2016
Q2 | $1.05M | Buy |
10,991
+46
| +0.4% | +$4.58K | 0.5% | 59 |
|
|
2016
Q1 | $1.14M | Buy |
10,945
+1,490
| +16% | +$145K | 0.55% | 56 |
|
|
2015
Q4 | $924K | Buy |
9,455
+19
| +0.2% | +$1.86K | 0.44% | 70 |
|
|
2015
Q3 | $910K | Buy |
9,436
+1,100
| +13% | +$116K | 0.39% | 74 |
|
|
2015
Q2 | $874K | Buy |
8,336
+223
| +3% | +$22.8K | 0.34% | 78 |
|
|
2015
Q1 | $837K | Buy |
8,113
+450
| +6% | +$45.5K | 0.34% | 78 |
|
|
2014
Q4 | $738K | Buy |
7,663
+3
| +0% | +$264 | 0.32% | 83 |
|
|
2014
Q3 | $610K | Buy |
7,660
+413
| +6% | +$32.6K | 0.27% | 97 |
|
|
2014
Q2 | $546K | Buy |
7,247
+659
| +10% | +$49.8K | 0.24% | 110 |
|
|
2014
Q1 | $493K | Buy |
6,588
+2,118
| +47% | +$150K | 0.23% | 118 |
|
|
2013
Q4 | $320K | Buy |
+4,470
| New | +$287K | 0.15% | 140 |
|
Other funds holding CVS
Boyd Watterson Asset Management's CVS Position: Q2 2026 in Review
Boyd Watterson Asset Management held its CVS Health (CVS) position steady in Q2 2026 at 435 shares worth $45K. The position accounts for 0.01% of the portfolio, ranked #194.
Boyd Watterson Asset Management first reported a position in CVS in Q4 2013 and has held it in 39 quarters since. The position peaked at $1.14M in Q1 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Boyd Watterson Asset Management held 435 shares of CVS Health worth $45K as of Q2 2026.
- Boyd Watterson Asset Management left its CVS Health share count unchanged in Q2 2026.
- CVS Health made up 0.01% of Boyd Watterson Asset Management's portfolio in Q2 2026, its #194 holding.
- Boyd Watterson Asset Management first reported a position in CVS Health in Q4 2013 and has held it in 39 quarters since.
- Boyd Watterson Asset Management's CVS Health position peaked at $1.14M in Q1 2016.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Boyd Watterson Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.